Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928758 · ClinicalTrials.gov registry record · NA
Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 245
- Enrollment target
NCT01928758 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 245 participants.
The verdict
NCT01928758, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
Study Summary
The overall aim of this project is to evaluate the effect of progressive nicotine reduction in cigarettes on smoking behavior, toxin exposure and psychiatric symptoms in smokers with comorbid mood and/or anxiety disorders. Smokers with mood and/or anxiety disorder will smoke research cigarettes that will contain either a) nicotine content similar to their preferred usual brand of cigarettes, or b) nicotine content per cigarette that is progressively reduced from approximately 11.6 mg to 0.2 mg per cigarette over 18 weeks. It is our hypothesis that nicotine intake will decline as a function of cigarette nicotine content in the Reduced Nicotine Content group without significant increases in tobacco smoke exposure, severity of nicotine withdrawal symptoms, mood and anxiety symptomatology or protocol non-adherence over time in the Reduced Nicotine Content group as compared with the control group.
Interventions
- DRUG Reduced Nicotine Content Cigarettes
- DRUG Usual Nicotine Content Cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-03-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01928758
The ClinicalTrials.gov registry entry for NCT01928758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Reduced Nicotine Content Cigarettes is the first listed.
NCT01928758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01928758 about?
NCT01928758 is a clinical study titled "Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders". The overall aim of this project is to evaluate the effect of progressive nicotine reduction in cigarettes on smoking behavior, toxin exposure and psychiatric symptoms in smokers with comorbid mood and/or anxiety disorders. Smokers with mood and/or anxiety disorder will smoke research cigarettes tha...
What is the current status of trial NCT01928758?
This trial is currently completed. It is a NA study. The enrollment target is 245 participants. The study started on 2015-09. Estimated completion is 2018-03-23.
What interventions are being tested in trial NCT01928758?
The interventions under investigation include: Reduced Nicotine Content Cigarettes (DRUG), Usual Nicotine Content Cigarettes (DRUG).
Who is sponsoring clinical trial NCT01928758?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.